Holen Sie sich die Stockscreener-App
1.25
11.61%
0.13
Handel nachbörslich:
1.25
Schlusskurs vom Vortag:
$1.12
Offen:
$1.13
24-Stunden-Volumen:
427.46K
Relative Volume:
1.19
Marktkapitalisierung:
$27.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.76M
KGV:
-1.3441
EPS:
-0.93
Netto-Cashflow:
-
1W Leistung:
-6.72%
1M Leistung:
-39.61%
6M Leistung:
+6.84%
1J Leistung:
+78.57%
1-Tages-Spanne:
$1.13
$1.31
1-Wochen-Bereich:
$1.08
$1.39
52-Wochen-Spanne:
$0.6568
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Firmenname
Neurosense Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie NRSN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.25 | 27.55M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Aktie (NRSN) Neueste Nachrichten
Is NeuroSense Therapeutics Ltd.’s ROIC above industry averageMarket Sentiment Summary & Community Consensus Trade Alerts - 선데이타임즈
Traders Consider Averaging Down in NeuroSense Therapeutics Ltd. Equity WarrantJuly 2025 Pullbacks & Capital Protection Trade Alerts - 선데이타임즈
Should you hold or exit NeuroSense Therapeutics Ltd. nowReal-Time Investment Picks with Accuracy - Newser
Why NeuroSense Therapeutics Ltd. is moving todayFree Stock Screener With Smart Filters - Newser
Applying chart zones and confluence areas to NeuroSense Therapeutics Ltd. Equity WarrantFree Secure Return Focused Investment Plan - Newser
What institutional flow reveals about NeuroSense Therapeutics Ltd. Equity WarrantFree Community Verified Stock Suggestions - Newser
What indicators show strength in NeuroSense Therapeutics Ltd.Fundamental Forecast for Undervalued Stocks - Newser
Chart based exit strategy for NeuroSense Therapeutics Ltd.Weekly Outlook for Short Term Investors - Newser
Detecting price anomalies in NeuroSense Therapeutics Ltd. Equity Warrant with AIAlgorithmic Prediction of Market Breakouts - Newser
How hedge fund analytics apply to NeuroSense Therapeutics Ltd. stockSmart Money Strategy for Growth Stocks - Newser
NeuroSense Therapeutics Ltd. Equity Warrant Company Revenue and Profit Trends: A Deep DiveSecure Entry Point Finder with Analysis - Newser
Published on: 2025-08-08 18:28:49 - Newser
Can NeuroSense Therapeutics Ltd. Equity Warrant hit a new high this monthEarnings Based Stock Performance Forecast - Newser
Why NeuroSense Therapeutics Ltd. stock attracts strong analyst attentionFree Investment Strategy With Low Risk - Newser
Maxim Group Analyst Maintains Hold Rating on Neurosense Therapeutics Ltd. - AInvest
What Fibonacci levels say about NeuroSense Therapeutics Ltd. reboundReal-Time AI Generated Market Forecast - Newser
Should you wait for a breakout in NeuroSense Therapeutics Ltd.Early Buy Opportunity with Chart Triggers - Newser
What is NeuroSense Therapeutics Ltd. company’s growth strategyAchieve breakthrough investment performance - Jammu Links News
What are analysts’ price targets for NeuroSense Therapeutics Ltd. in the next 12 monthsInvest confidently with professional market insights - Jammu Links News
What institutional investors are buying NeuroSense Therapeutics Ltd. Equity Warrant stockAchieve breakthrough growth with proven strategies - Jammu Links News
What institutional investors are buying NeuroSense Therapeutics Ltd. stockDynamic growth stocks - Jammu Links News
How volatile is NeuroSense Therapeutics Ltd. stock compared to the marketConsistent wealth multiplication - Jammu Links News
How strong is NeuroSense Therapeutics Ltd. company’s balance sheetFree Consultation - Jammu Links News
What are NeuroSense Therapeutics Ltd. company’s key revenue driversAccelerate your capital gains today - Jammu Links News
How does NeuroSense Therapeutics Ltd. Equity Warrant generate profit in a changing economyBreakthrough stock performance - Jammu Links News
What are the technical indicators suggesting about NeuroSense Therapeutics Ltd. Equity WarrantConsistently profitable trades - Jammu Links News
What analysts say about NeuroSense Therapeutics Ltd. stockInvest confidently with actionable market data - Jammu Links News
NeuroSense Therapeutics Ltd. Equity Warrant Stock Analysis and ForecastTremendous financial leverage - Jammu Links News
What are the latest earnings results for NeuroSense Therapeutics Ltd. Equity WarrantDynamic portfolio growth - Jammu Links News
How does NeuroSense Therapeutics Ltd. Equity Warrant compare to its industry peersBreakthrough profit margins - Jammu Links News
When is NeuroSense Therapeutics Ltd. Equity Warrant stock expected to show significant growthAchieve fast wealth growth with smart picks - Jammu Links News
NeuroSense Therapeutics Ltd. Stock Analysis and ForecastNavigate market volatility with smart strategies - Jammu Links News
How does NeuroSense Therapeutics Ltd. compare to its industry peersBuild wealth faster with disciplined trading - Jammu Links News
How volatile is NeuroSense Therapeutics Ltd. Equity Warrant stock compared to the marketBuild a diversified portfolio for risk management - Jammu Links News
What is NeuroSense Therapeutics Ltd. Equity Warrant company’s growth strategyGet exclusive market analysis for investors - Jammu Links News
Is NeuroSense Therapeutics Ltd. a good long term investmentBreakthrough capital growth - Jammu Links News
Published on: 2025-08-03 03:33:27 - Jammu Links News
What makes NeuroSense Therapeutics Ltd. Equity Warrant stock price move sharplyGrow your wealth with proven stock picks - Jammu Links News
How many analysts rate NeuroSense Therapeutics Ltd. Equity Warrant as a “Buy”Stay ahead with daily expert stock picks - Jammu Links News
Volume Surge May Signal Institutional Interest in NeuroSense Therapeutics Ltd. Equity WarrantWeekly Stock Watch With Growth Focus Expanded - beatles.ru
Is NeuroSense Therapeutics Ltd. a growth stock or a value stockFree Stock Target Finder With Proven Results - Jammu Links News
NeuroSense Therapeutics: Navigating the ALS Treatment Frontier Amid Financial Constraints - AInvest
Neurosense Therapeutics shares rise 5.56% after-hours following a positive business update and progress report. - AInvest
NeuroSense Therapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
NeuroSense Therapeutics Advances ALS Treatment with Phase 3 Trial Plans - TipRanks
Sector Rotation Brings NeuroSense Therapeutics Ltd. Into FocusVerified Signal From Chart Patterns Detected - metal.it
NeuroSense's ALS Drug Achieves Breakthrough: 40% Slower Decline, 74% Better Survival as Phase 3 Nears - Stock Titan
Does NeuroSense Therapeutics Ltd. stock perform well during market downturnsExpert Picks Signals To Watch Now - Jammu Links News
NeuroSense Therapeutics Ltd. Equity Warrant stock prediction for this weekEntry Zone Strategy for Consistent Profit Shared - metal.it
Finanzdaten der Neurosense Therapeutics Ltd-Aktie (NRSN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):